Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas

Cancer Research

Volumn 56, Issue 10, 1996, Pages 2422-2427

  Krajewska, Maryla ^a   Moss, Steven F ^b   Krajewski, Stanislaw ^a   Song, Ki ^a   Holt, Peter R ^b   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REGULATOR PROTEIN;

ARTICLE; COLON ADENOCARCINOMA; COLON MUCOSA; CONTROLLED STUDY; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTO ONCOGENE; RECTUM CARCINOMA;

ADENOCARCINOMA; ADENOMA; AMINO ACID SEQUENCE; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0029945789     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Boring, C. C., Squires, T. S., and Tong, T. S. Cancer statistics. CA Cancer J. Clin , 44: 7-26, 1994
2. Steel, G. G. Growth Kinetics of Tumors. London Oxford University Press, 1977.
3. Sarraf, C. E., and Bowen, I. D. Proportion of mitotic and apoptotic cells in a range of untreated experimental tumors. Cell Tissue Kinet., 21: 45-49, 1988
4. Deschner, E E. Kinetics of Normal, Preneoplastic, and Neoplastic Colonic Epithelium, p. 41 San Diego: Academic Press, Inc., 1990.
5. Bedi, A., Pasricha, P. J., Akhtar, A. J., Barber, J. P., Bedi, G. C., Giardiello, F. M , Zehnbauer, B A., Hamilton, S. R , and Jones, R. J. Inhibition of apoptosis during development of colorectal cancer Cancer Res., 55: 1811-1816, 1995.
6. Reed, J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124: 1-6, 1994
7. Vaux, D. L. Toward an understanding of the molecular mechanisms of physiological cell death Proc. Natl. Acad. Sci. USA, 90: 786-789, 1993.
8. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease Science (Washington DC), 267: 1456-1462, 1995
9. Oltvai, Z. N., and Korsmeyer, S. J. Checkpoints of dueling dimers foil death wishes Cell, 79: 189-192, 1994
10. Oltvai, Z , Milliman, C., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
11. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L A., Mao, X., Nunez, G., and Thompson, C. B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptocic cell death. Cell, 74: 597-608, 1993
12. Sato, T., Hanada, M., Bodrug, S., Irie, S , Iwama, N., Boise, L. H , Thompson, C. B., Golemis, E , Fong, L., Wang, H-G., aad Reed, J. C Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad Sci. USA, 91: 9238-9242, 1994.
13. Hanada, M., Aimé-Sempé, C., Sato, T., and Reed, J. C. Structure-function analysis of bcl-2 protein identification of conserved domains importants for homodimerization with bcl-2 and heterodimerization with bax. J. Biol. Chem., 270: 11962-11968, 1995.
14. L and Bcl-2, displaces bax and promotes cell death. Cell, 80. 285-291, 1995
15. Farrow, S. N., White, J. H. M., Martinou, I., Raven, T , Pun, K-T., Grinham, C. J., Martinou, J-C., and Brown, R. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature (Lond.), 374: 731-733, 1995.
16. Chittenden, T., Harrington, E. A , O'Connor, R., Flemington, C., Lutz, R. J., Evan, G. I., and Guild, B. C. Induction of apoptosis by the Bcl-2 homologue Bak Nature (Lond.), 374: 733-736, 1995.
17. Kiefer, M C., Brauer, M J., Powers, V. C., Wu, J. J., Ubansky, S. R., Tomei, L. D , and Barr, P. J. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature (Lond.), 374: 736-739, 1995.
18. Bodrug, S. E., Aimé-Sempé, C., Sato, T., Krajewski, S., Hanada, M., and Reed, J. C. Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: evidence for a novel mechanism of regulating Bcl-2 family protein function. Cell Death Differ., 2: 173-182, 1995.
19. Reynolds, J. E., Yang, T , Qian, L., Jenkinson, J. D., Zhou, P , Eastman, A., and Craig, R. W. Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-myc overexpression in Chinese hamster ovary cells. Cancer Res., 54: 6348-6352, 1994.
20. Ruoslahti, E , and Reed, J C. Anchorage dependence, integrins, and apoptosis. Cell, 77 477-478, 1994.
21. Reed, J. C. Bcl-2: prevention of apoptosis as a mechanism of drug resistance. Hematol. Oncol. Clin. N. Am., 9: 451-474, 1995.
22. Krajewski, S., Bodrug, S., Gascoyne, R., Berean, K., Krajewska, M., and Reed, J. C. Immunohistochemical analysis of mcl-1 and bcl-2 proteins in normal and neoplastic lymph nodes. Am J. Pathol., 145: 515-525, 1994.
23. Krajewski, S., Krajewska, M., Shabaik, A., Wang, H-G., Irie, S., Fong, L , and Reed, J. C. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res., 54: 5501-5507, 1994.
24. Krajewski, S., Bodrug, S., Krajewska, M., Shabaik, A., Gascoyne, R., Berean, K., and Reed, J. C. Immunohistochemical analysis of Mcl-1 protein in human tissues: differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am. J. Pathol., 146: 1309-1319, 1995.
25. Krajewski, S., Blomvqvist, C , Franssila, K., Krajewska, M., Wasenius, V-M., Niskanen, E., and Reed, J. C. Reduced expression of pro-apoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res., 55: 4471-4478, 1995.
26. Krajewski, S., Chatten, J , Hanada, M , Womer, R., and Reed, J. C. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Lab. Invest., 72: 42-54, 1994.
27. Haldar, S., Jena, N , and Croce, C. M. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA, 92: 4507-4511, 1995.
28. L can confer a multidrug resistance phenotype. Blood, 86: 1903-1910, 1995.
29. Sugarbaker, J P , Gunderson, L. L., and Wittes, R. E Cancer: Principles and Practice of Oncology. Philadelphia: J. B Lippincott Co., 1985.
30. Hellemans, P., van Dam, P A., Weyler, J., van Oosterom, A. T., Buytaert, P., and Van Marck, E. Prognostic value of bcl-2 expression in invasive breast cancer. Br J Cancer, 72: 354-360, 1995.
31. Nathan, B , Gusterson, B., Jadayel, D., O'Hare, M , Anbazhagan, R., Jayatilake, H , Ebbs, S., Micklem, K., Price, K., and Gelber, R. Expression of Bcl-2 in primary breast cancer and its correlation with tumour phenotype. For the International (Ludwig) Breast Cancer Study Group. Ann. Oncol., 5: 409-414, 1994.
32. Doglioni, C., Dei Tos, A. P., Laurino, L , Chiarelli, C., Barbareschi, M., and Viale, G. The prevalence of Bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Arch. A Pathol. Anat. Histol., 424: 47-51, 1994.
33. Pezzella, F., Turley, H , Kuzu, I., Tungekar, M. F., Dunnill, M. S., Pierce, C. B , Harris, A , Gatter, K. C , and Mason, D. Y. Bcl-2 protein in non-small cell lung carcinoma, N. Engl. J. Med, 329: 690-694, 1993.
34. Pilotti, S., Collini, P., Rilke, F , Cattoretti, G., Del Bo, R., and Pierotti, M. A. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol , 172: 337-342, 1994.
35. Hague, A , Moorghen, M., Hicks, D., Chapman, M., and Paraskeva, C. Bcl-2 expression in human colorectal adenomas and carcinomas. Oncogene, 9: 3367-3370, 1994.
36. Bronner, M., Culin, C , Reed, J. C., and Furth, E. E. Bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am. J. Pathol., 146: 20-26, 1995.
37. Bargou, R. C , Daniel, P. T , Mapara, M. Y , Bommert, K., Wagenert, K , Wagener, C., Kallinich, B., Royer, H. D., and Dörken, B. Expression of the bcl-2 gene family in normal and malignant breast tissue, low bax-a expression in tumor cells correlates with resistance towards apoptosis. Int. J. Cancer, 60: 854-859, 1995.
38. Knudson, C. M , Tung, K S. K., Tourtellotte, W. G., Brown, G. A. J., and Korsmeyer, S J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science (Washington DC), 270: 96-99, 1995.
39. Guan, R J., Moss, S. F., Arber, N., Krajewski, S., Reed, J. C., and Holt, P R. 30 Kda phosphorylated form of Bcl-2 protein in human colon. Oncogene, in press, 1996.